EE624 Public Health Impact of Introducing Adjuvanted Recombinant Zoster Vaccine into the Vaccination Programme in the UK

Abstract

Authors

M Hunjan D Curran A Marijam J Schamroth Y Vekria N Giannelos

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×